M-CSF attenuates severity of chronic GVHD after unrelated BMT

Bone Marrow Transplantation

Volumn 47, Issue 3, 2012, Pages 426-429

  Kimura, F ^a   Sato, K ^a   Akiyama, H ^b   Sao, H ^c   Okamoto, S ^d   Kobayashi, N ^e   Hara, M ^f   Kawa, K ^g   Motoyoshi, K ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c Meitetsu Hospital   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Res Institute for Artificial Organs   (Japan)

^f EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^g RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

chronic GVHD; M CSF; unrelated BMT

Indexed keywords

COLONY STIMULATING FACTOR 1;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 85027925804     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.90     Document Type: Article

References (21)

1. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry. N Engl J Med 1999; 341: 14-21.
2. Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406-414. (Pubitemid 34761100)
3. Chao NJ, Parker PM, Niland JC, Wong RM, Dagis A, Long GD et al. Paradoxical effect of thalidomide prophylaxis on chronic graft-vs-host disease. Biol Blood Marrow Transplant 1996; 2: 86-92. (Pubitemid 126488199)
4. Kansu E, Gooley T, Flowers ME, Anasetti C, Deeg HJ, Nash RA et al. Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial. Blood 2001; 98: 3868-3870.
5. Mengarelli A, Iori AP, Romano A, Cerretti R, Cerilli L, De Propris MS et al. One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. Haematologica 2003; 88: 315-323. (Pubitemid 36358720)
6. Masaoka T, Shibata H, Ohno R, Katoh S, Harada M, Motoyoshi K et al. Double-blind test of human urinary macrophage colony-stimulating factor for allogeneic and syngeneic bone marrow transplantation: effectiveness of treatment and 2-year follow-up for relapse of leukaemia. Br J Haematol 1990; 76: 501-505.
7. Ohno R, Miyawaki S, Hatake K, Kuriyama K, Saito K, Kanamaru A et al. Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study. J Clin Oncol 1997; 15: 2954-2965. (Pubitemid 27330024)
8. Li G, Kim YJ, Broxmeyer HE. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential. J Immunol 2005; 174: 4706-4717.
9. Kwan WH, Boix C, Gougelet N, Fridman WH, Mueller CG. LPS induces rapid IL-10 release by M-CSF-conditioned tolerogenic dendritic cell precursors. J Leukoc Biol 2007; 82: 133-141. (Pubitemid 47026425)
10. Hashimoto D, Chow A, Greter M, Leboeuf M, Ginhoux F, Teshima T et al. Pre-transplant CSF-1 therapy expands the recipient macrophage pool and modulates graft versus host disease after allogeneic hematopoietic cell transplantation. Blood 2010; 116: abstract 242.
11. Sakata N, Yasui M, Okamura T, Inoue M, Yumura-Yagi K, Kawa K. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Transplant 2001; 27: 1153-1161. (Pubitemid 32600288)
12. Barak V, Levi-Schaffer F, Nisman B, Nagler A. Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma 1995; 17: 169-173.
13. Liem LM, Fibbe WE, van Houwelingen HC, Goulmy E. Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation 1999; 67: 59-65. (Pubitemid 29061137)
14. Korholz D, Kunst D, Hempel L, Sohngen D, Heyll A, Bonig H et al. Decreased interleukin 10 and increased interferongamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 691-695. (Pubitemid 27182492)
15. Smith W, Feldmann M, Londei M. Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. Eur J Immunol 1998; 28: 2498-2507. (Pubitemid 28362724)
16. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618. (Pubitemid 34925136)
17. Sugimoto K, Narimatsu H, Kawase T, Iida H, Watanabe M, Kohno A et al. Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults. Bone Marrow Transplant 2008; 41: 729-736. (Pubitemid 351587038)
18. Narimatsu H, Miyakoshi S, Yamaguchi T, Kami M, Matsumura T, Yuji K et al. Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1,072 patients in Japan. Blood 2008; 112: 2579-2582.
19. Saito S, Motoyoshi K, Ichijo M, Saito M, Takaku F. High serum human macrophage colony-stimulating factor level during pregnancy. Int J Hematol 1992; 55: 219-225.
20. Ikeno K, Koike K, Fukuromoto T, Shimizu T, Nagatomo M, Komiyama A. Increased macrophage-colony stimulating factor levels in neonates with perinatal complications. Early Hum Dev 1996; 46: 229-237. (Pubitemid 26370848)
21. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956. (Pubitemid 41754712)